Blog

Jul 27, 2024, 09:42

TIP Regimen in Germ Cell Tumors: Long-Term Outcomes

Yüksel Ürün shared on X:

“TIP Regimen in Germ Cell Tumors: Long-Term Outcomes

Paclitaxel, Ifosfamide, Cisplatin (TIP) is a proven salvage therapy for GCT.
104 patients: 87 favorable risk, 17 unfavorable risk. 5-year PFS: 66%, OS: 69%.
Effective for both favorable and unfavorable risks.
Awaiting TIGER trial results for optimal 2nd-line therapy.

‘Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease‘

Authors: Jack P. Gleeson, Andrea Knezevic, Maria Bromberg, Sujata Patil, Joel Sheinfeld, Brett S. Carver, Manjit Bains, David R. Jones, Dean F. Bajorin, George J. Bosl, Deaglan J. McHugh, Samuel A. Funt, Robert J. Motzer, and Darren R. Feldman.”

Yüksel Ürün

Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.

Andrea Knezevic Brett S. Carver cancer Darren R. Feldman David R. Jones Deaglan J. McHugh Dean F Bajorin George J. Bosl Germ Cell Tumors Jack P. Gleeson Joel Sheinfeld Manjit Bains Maria Bromberg OncoDaily Oncology Robert J. Motzer Samuel A. Funt Sujata Patil Yüksel Ürün

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage